449 related articles for article (PubMed ID: 8049086)
1. [Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia].
Brandão L; de Sousa J; Barreiros MC; Vagueiro MC; Amram SS
Rev Port Cardiol; 1994 Mar; 13(3):197-202, 191. PubMed ID: 8049086
[TBL] [Abstract][Full Text] [Related]
2. [Wolff-Parkinson-White syndrome with orthodromic supraventricular tachycardia associated with a "hyper-conductor" atrio-ventricular node. A therapeutic challenge].
Hernández González D; Iturralde Torres P; Romero L; Colín L; Villarreal A; González Hermosillo JA
Arch Inst Cardiol Mex; 1990; 60(2):175-81. PubMed ID: 2378538
[TBL] [Abstract][Full Text] [Related]
3. [The diagnostic and therapeutic usefulness of adenosine triphosphate in supraventricular tachycardias].
Pulignano G; Patruno N; Urbani P; Critelli G
Cardiologia; 1990 Aug; 35(8):671-7. PubMed ID: 2078847
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of adenosine triphosphate in terminating supraventricular tachycardia].
Schläpfer J; Fromer M; Kappenberger L
Schweiz Med Wochenschr; 1993 May; 123(18):941-4. PubMed ID: 8497781
[TBL] [Abstract][Full Text] [Related]
5. Comparative clinical and electrophysiologic effects of adenosine and verapamil on termination of paroxysmal supraventricular tachycardia.
Sethi KK; Singh B; Kalra GS; Arora R; Khalilullah M
Indian Heart J; 1994; 46(3):141-4. PubMed ID: 7821934
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
Gambhir DS; Bhargava M; Arora R; Khalilullah M
Indian Heart J; 1995; 47(3):237-43. PubMed ID: 7558090
[TBL] [Abstract][Full Text] [Related]
7. [Terminating supraventricular tachycardia with adenosine--comparing the effectiveness of 12 mg and 18 mg].
Weismüller P; Kattenbeck K; Heinroth KM; Ranke C; Trappe HJ
Dtsch Med Wochenschr; 2000 Aug; 125(33):961-9. PubMed ID: 10994404
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
Purcaro A; Capestro F; Ciampani N; Fratadocchi GB; Mazzanti M; Costantini C; Molini E
G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of the pre-excitation index to determine the mechanism of supraventricular paroxysmal tachycardia and the location of the anomalous pathway].
Hernández González D; Iturralde Torres P; Colín L; Gutiérrez A; González Hermosillo JA
Arch Inst Cardiol Mex; 1990; 60(2):145-52. PubMed ID: 2378534
[TBL] [Abstract][Full Text] [Related]
10. [Electrophysiologic effect of a new Ca(2+)-antagonist, TA-3090 on supraventricular tachycardia and conduction system].
Tanno K; Kobayashi Y; Miyata A; Chiyoda K; Nakagawa H; Kurano K; Kikushima S; Yazawa T; Baba T; Mukai H
Kokyu To Junkan; 1992 Sep; 40(9):897-902. PubMed ID: 1439290
[TBL] [Abstract][Full Text] [Related]
11. Adenosine: a clinical experience and comparison with verapamil for the termination of supraventricular tachycardias.
Sellers TD; Kirchhoffer JB; Modesto TA
Prog Clin Biol Res; 1987; 230():283-99. PubMed ID: 3295883
[TBL] [Abstract][Full Text] [Related]
12. [Catheter ablation in supraventricular tachycardia].
Pitschner HF; Neuzner J
Z Kardiol; 1996; 85 Suppl 6():45-60. PubMed ID: 9064982
[TBL] [Abstract][Full Text] [Related]
13. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
Pfitzner P; Manz M; Schütz R; Lüderitz B
Z Kardiol; 1989 Oct; 78(10):654-60. PubMed ID: 2686252
[TBL] [Abstract][Full Text] [Related]
14. Clinical and electrophysiologic effects of magnesium sulfate on paroxysmal supraventricular tachycardia and comparison with adenosine triphosphate.
Viskin S; Belhassen B; Sheps D; Laniado S
Am J Cardiol; 1992 Oct; 70(9):879-85. PubMed ID: 1529941
[TBL] [Abstract][Full Text] [Related]
15. [Exogenous adenosine as an anti-arrhythmia agent].
Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
[TBL] [Abstract][Full Text] [Related]
16. Accessory pathway reciprocating tachycardia.
Obel OA; Camm AJ
Eur Heart J; 1998 May; 19 Suppl E():E13-24, E50-1. PubMed ID: 9717020
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness of transesophageal electrophysiological study during the ergometric test in the evaluation of supraventricular paroxysmal tachycardia occurring during exertion].
Delise P; D'Este D; Bonso A; Allibardi P; Raviele A; Di Pede F; Piccolo E
G Ital Cardiol; 1989 Dec; 19(12):1094-104. PubMed ID: 2576799
[TBL] [Abstract][Full Text] [Related]
18. Unusual induction of slow-fast atrioventricular nodal reentrant tachycardia. Report of two cases.
Calò L; Riccardi R; Scaglione M; Caponi D; Golia P; Gaita F
G Ital Cardiol; 1999 Nov; 29(11):1318-22. PubMed ID: 10609133
[TBL] [Abstract][Full Text] [Related]
19. Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia.
Hammill SC; McLaran CJ; Wood DL; Osborn MJ; Gersh BJ; Holmes DR
J Am Coll Cardiol; 1987 Jun; 9(6):1364-8. PubMed ID: 3584724
[TBL] [Abstract][Full Text] [Related]
20. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia].
Musto B; D'Onofrio A; Cavallaro C; Musto A; Della Gatta O; Marsico F
G Ital Cardiol; 1987 May; 17(5):444-9. PubMed ID: 3115857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
